- Home
- NKTR vs SHLS Comparison
NKTR vs SHLS Comparison
Compare NKTR & SHLS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | NKTR | SHLS |
|---|---|---|
| Founded | 1990 | 1996 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Semiconductors |
| Sector | Health Care | Technology |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.3B | 1.3B |
| IPO Year | 1996 | 2020 |
Fundamental Metrics
Financial Performance| Metric | NKTR | SHLS |
|---|---|---|
| Price | $37.24 | $8.11 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 15 | 14 |
| Target Price | ★ $133.08 | $11.39 |
| AVG Volume (30 Days) | 599.5K | ★ 7.0M |
| Earning Date | 11-12-2026 | 11-04-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 42.86 |
| EPS | N/A | ★ 0.17 |
| Revenue | $307,711,000.00 | ★ $475,331,000.00 |
| Revenue This Year | N/A | $41.01 |
| Revenue Next Year | $27.72 | $7.37 |
| P/E Ratio | ★ N/A | $51.32 |
| Revenue Growth | ★ 86.00 | 19.07 |
| 52 Week Low | $33.40 | $5.55 |
| 52 Week High | $109.00 | $13.18 |
Technical Indicators
Market Signals| Indicator | NKTR | SHLS |
|---|---|---|
| Relative Strength Index (RSI) | 38.33 | 49.82 |
| Support Level | $35.68 | $7.84 |
| Resistance Level | $40.12 | $8.54 |
| Average True Range (ATR) | 1.55 | 0.80 |
| MACD | 0.90 | 0.05 |
| Stochastic Oscillator | 37.77 | 35.34 |
Price Performance
Historical ComparisonAbout NKTR Nektar Therapeutics
Nektar Therapeutics is a clinical-stage, research-based biopharmaceutical company headquartered in San Francisco, California, and incorporated in Delaware, focused on discovering and developing medicines in the field of immunotherapy. The Company directs its efforts toward creating immunomodulatory agents that selectively induce, amplify, attenuate, or prevent immune responses to achieve desired therapeutic outcomes. Its pipeline of clinical-stage and preclinical-stage immunomodulatory agents targets the treatment of autoimmune diseases, including rezpegaldesleukin, NKTR-0165, NKTR-0166, and NKTR-422, as well as cancer, including NKTR-255.
About SHLS Shoals Technologies Group Inc.
Shoals Technologies Group is a provider of electrical balance of system solutions for solar energy projects, primarily in the United States. EBOS encompasses components that are necessary to carry electric current produced by solar panels to an inverter. The products are sold principally to engineering, procurement, and construction firms that build solar energy projects.